Remimazolam

Description

Remimazolam · CAS 308242-62-8 · C21H19BrN4O2. UNII 7V4A8U16MB.

Identification

Computed Descriptors

Physical description & handling notes

• Sparingly soluble

Documented Uses

• Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
• Remimazolam is an ultra-short acting benzodiazepine used intravenously for induction and maintenance of sedation for adults undergoing short term procedures not requiring general anesthesia. Remimazolam sedation has not been associated with serum aminotransferase elevations and has not been linked to cases of clinically apparent liver injury.
• Breast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Benzodiazepines; Anesthetics, Intravenous
• Schedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.
• Avoid alcohol. The sedative effects of benzodiazepines may be exacerbated by the co-administration of alcohol.
• N05CD - Benzodiazepine derivatives

Synonyms

Remimazolam; 308242-62-8; CNS 7056; CNS-7056; ONO-2745; 7V4A8U16MB; ONO2745; 4H-Imidazo(1,2-a)(1,4)benzodiazepine-4-propanoic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-, methyl ester, (4S)-; CNS7056; remimazolamum; RefChem:57866; N05CD14; methyl 3-((4S)-8-bromo-2-methyl-6-pyridin-2-yl-4H-imidazo(1,2-a)(1,4)benzodiazepin-4-yl)propanoate; Byfavo (TN); Remimazolam [INN]; UNII-7V4A8U16MB

Frequently Asked Questions

What are the CAS number and molecular formula of Remimazolam?

CAS 308242-62-8; molecular formula C21H19BrN4O2; molecular weight — g/mol.

What other names is Remimazolam known by?

Remimazolam, 308242-62-8, CNS 7056, CNS-7056, ONO-2745, 7V4A8U16MB.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.